Middle East and Africa Molecular Biology Enzymes, Kits, and Reagents Market Forecast by 2028
Middle East and Africa Molecular Biology Enzymes, Kits, and Reagents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Enzymes and Kits & Reagents), Application (Epigenetics, Sequencing, Synthetic Biology, Polymerase Chain Reaction, and Other), and End User (Biotechnological & Pharmaceutical Companies, Hospitals & Diagnostic Centers, and Academic & Research Institutes)
- Report Date : Nov 2021
- Report Code : TIPRE00025776
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 167
The molecular biology enzymes, kits, and reagents market in MEA is expected to grow from US$ 537.68 million in 2021 to US$ 1,566.09 million by 2028; it is estimated to grow at a CAGR of 16.5% from 2021 to 2028.
Saudi Arabia, South Africa, and UAE are major economies in MEA. Personalized medicines are at high demand and this is the major factor driving the growth of the MEA molecular biology enzymes, kits, and reagents market. According to the WHO suggestions, 30–50% of deaths caused due to cancer can be prevented by adequate treatment in early stages. In this scenario, personalized medicine offers the most promising approach to tackle diseases that have not been well-known for responding effectively to the existing treatments or cures. As per a study published in the PMC, personalized medicines accounted for only 5% of the new FDA-approved molecular entities in 2005, whereas they accounted for more than 25% of the same in 2016. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be personalized medicines. Moreover, biopharmaceutical companies have nearly doubled their R&D investments in personalized drugs in the past five years, and they are expected to increase by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the number of personalized medicines in development in the coming five years.Economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and cannot implement any public health measures. Iran was in a deep economic recession due to the US sanctions. Also, the major source of economic stabilization in the Middle East countries is oil production and export. However, the recent pandemic is causing turbulence to the economies of the Middle East region. A sudden drop in domestic and external demand for goods and products, especially crude oil, and halted production due to labor shortage are major impacts observed in the region.The Saudi government policies favor domestic pharmaceutical manufacturers, including no import duties on raw materials & intermediate products and interest-free funding, thus supporting the growth of the pharmaceutical market in this region.
Similarly, the increasing incidence of COVID-19 is creating a massive demand for kits and reagents used to detect the COVID-19 virus. In April 2020, BGI Group, a Chinese genomics company, and Group-42, a UAE technology company, unveiled a new massive-throughput laboratory in the UAE to help with testing and diagnosis of the novel coronavirus. According to BGI, the lab will use RT-PCR diagnostic kits that have been approved by medical regulatory authorities in China, Europe, the US, and Japan. As molecular biology enzymes, kits, and reagents are majorly used in the detection of a novel coronavirus, so there was a high impact of COVID-19 on the molecular biology enzymes, kits & reagents market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA molecular biology enzymes, kits, and reagents market. The MEA molecular biology enzymes, kits, and reagents market is expected to grow at a good CAGR during the forecast period.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
MEA Molecular Biology Enzymes, Kits, and Reagents Market Segmentation
MEA Molecular Biology Enzymes, Kits, and Reagents Market – By Product
Enzymes
- Polymerases
- Ligases
- Reverse Transcriptases
- Phosphatases
- Proteases and Proteinases
- Restriction Endonuclease
- Other
- Kits and Reagents
MEA Molecular Biology Enzymes, Kits, and Reagents Market – By Application
- Epigenetics
- Sequencing
- Synthetic Biology
- Polymerase Chain Reaction
- Other
MEA Molecular Biology Enzymes, Kits, and Reagents Market – By End User
- Biotechnological and Pharmaceutical Companies
- Hospitals and Diagnostic Centres
- Academic and Research Institutes
MEA Molecular Biology Enzymes, Kits, and Reagents Market, by Country
- Saudi Arabia
- South Africa
- UAE
- Rest of MEA
MEA Molecular Biology Enzymes, Kits, and Reagents Market - Companies Mentioned
- Agilent Technologies, Inc.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Merck KGAA
- MERIDIAN BIOSCIENCE, INC
- Promega Corporation
- Qiagen
- THERMO FISHER SCIENTIFIC INC
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Molecular Biology Enzymes, Kits & Reagents Market – By Product
1.3.2 MEA Molecular Biology Enzymes, Kits & Reagents Market – By Application
1.3.3 MEA Molecular Biology Enzymes, Kits & Reagents Market – By End-User
1.3.4 MEA Molecular Biology Enzymes, Kits & Reagents Market – By Country
2. MEA Molecular Biology Enzymes, Kits & Reagents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Molecular Biology Enzymes, Kits & Reagents Market – Market Landscape
4.1 MEA PEST Analysis
4.1.1 Expert Opinion
5. MEA Molecular Biology Enzymes, Kits & Reagents Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Genomics Getting Hefty Fundings
5.1.2 Sequencing Procedures Getting Affordable
5.1.3 Surge in Chronic Diseases Prevalence
5.2 Market Restraints
5.2.1 Skilled Professionals are in Scarce Supply
5.3 Market Opportunities
5.3.1 Molecular Diagnostics Getting More Widely Known
5.4 Future Trends
5.4.1 Personalized Medicines are in High Demand
5.5 Impact analysis
6. Molecular Biology Enzymes, Kits & Reagents Market – MEA Analysis
6.1 MEA Molecular Biology Enzymes, Kits & Reagents Market Revenue Forecast and Analysis
7. MEA Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Product
7.1 Overview
7.2 MEA Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)
7.3 Enzymes
7.3.1 Overview
7.3.2 Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Polymerases
7.3.3.1 Overview
7.3.3.2 Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Ligase
7.3.4.1 Overview
7.3.4.2 Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Reverse Transcriptases
7.3.5.1 Overview
7.3.5.2 Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Phosphatases
7.3.6.1 Overview
7.3.6.2 Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.7 Proteases and Proteinases
7.3.7.1 Overview
7.3.7.2 Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.8 Restriction Endonuclease
7.3.8.1 Overview
7.3.8.2 Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.9 Other
7.3.9.1 Overview
7.3.9.2 Other: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Kits and Reagents
7.4.1 Overview
7.4.2 Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8. MEA Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Application
8.1 Overview
8.2 MEA Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)
8.3 Polymerase Chain Reaction
8.3.1 Overview
8.3.2 Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Sequencing
8.4.1 Overview
8.4.2 Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Synthetic Biology
8.5.1 Overview
8.5.2 Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Epigenetics
8.6.1 Overview
8.6.2 Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9. MEA Molecular Biology Enzymes, Kits & Reagents Market – By End User
9.1 Overview
9.2 MEA Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)
9.3 Biotechnological and Pharmaceutical Companies
9.3.1 Overview
9.3.2 Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals and Diagnostic Centers
9.4.1 Overview
9.4.2 Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
10. MEA Molecular Biology Enzymes, Kits & Reagents Market – Country Analysis
10.1 Overview
10.1.1 MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)
10.1.1.1 Saudi Arabia
10.1.1.1.1 Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.2 Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.1.3 Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.1.4 Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.1.5 Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.1.2 South Africa
10.1.1.2.1 South Africa: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.2 South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.2.3 South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.2.4 South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.2.5 South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.1.3 UAE
10.1.1.3.1 UAE: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.2 UAE: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.3.3 UAE: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.3.4 UAE: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.3.5 UAE: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.1.4 Rest of MEA
10.1.1.4.1 Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.2 Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.4.3 Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.4.4 Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.4.5 Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on Global Molecular Biology Enzymes, Kits & Reagents Market
11.1 MEA: Impact Assessment of COVID-19 Pandemic
12. Molecular Biology Enzymes, Kits & Reagents Market Industry Landscape
12.1 Overview
12.2 Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market, 2018-2021
12.3 Organic Growth Strategies
12.3.1 Overview
12.3.2 Recent Organic Developments in the Molecular Biology Enzymes, Kits & Reagents Market
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 MERCK KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Illumina, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 QIAGEN
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Agilent Technologies, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 THERMO FISHER SCIENTIFIC INC.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 MERIDIAN BIOSCIENCE, INC.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Promega Corporation
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 2. Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 6. South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 7. South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 8. South Africa: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 9. UAE: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 10. UAE: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 11. UAE: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 12. UAE: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. Recent Inorganic Developments In The Molecular Biology Enzymes, Kits & Reagents Market
Table 18. Glossary of Terms, Molecular Biology Enzymes, Kits & Reagents Market
LIST OF FIGURES
Figure 1. MEA Molecular Biology Enzymes, Kits & Reagents Market Segmentation
Figure 2. MEA Molecular Biology Enzymes, Kits & Reagents Market Segmentation, By Country
Figure 3. MEA Molecular Biology Enzymes, Kits & Reagents Market Overview
Figure 4. Kits and Reagents Segment Held Largest Share of MEA Molecular Biology Enzymes, Kits & Reagents Market
Figure 5. North America to Show Remarkable Growth During Forecast Period
Figure 6. MEA PEST Analysis
Figure 7. MEA Molecular Biology Enzymes, Kits, and Reagents Market Impact Analysis of Driver and Restraints
Figure 8. MEA Molecular Biology Enzymes, Kits & Reagents Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. MEA Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)
Figure 10. MEA Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. MEA Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. MEA Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. MEA Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. MEA Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. MEA Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. MEA Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. MEA Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. MEA Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. MEA Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)
Figure 20. MEA Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. MEA Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. MEA Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. MEA Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. MEA Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. MEA Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)
Figure 26. MEA Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. MEA Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. MEA Academic and Research Institute: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Key Country – Revenue (2020) (USD Million)
Figure 30. MEA: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)
Figure 31. Saudi Arabia: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. South Africa: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. UAE: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Rest of MEA: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in MEA Country Markets
Figure 36. Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market
- Agilent Technologies, Inc.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Merck KGAA
- MERIDIAN BIOSCIENCE, INC
- Promega Corporation
- Qiagen
- THERMO FISHER SCIENTIFIC INC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For